Chen S. Suen

844 total citations
23 papers, 690 citations indexed

About

Chen S. Suen is a scholar working on Pharmacology, Oncology and Genetics. According to data from OpenAlex, Chen S. Suen has authored 23 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 7 papers in Oncology and 7 papers in Genetics. Recurrent topics in Chen S. Suen's work include Inflammatory mediators and NSAID effects (9 papers), Estrogen and related hormone effects (7 papers) and Cancer, Stress, Anesthesia, and Immune Response (4 papers). Chen S. Suen is often cited by papers focused on Inflammatory mediators and NSAID effects (9 papers), Estrogen and related hormone effects (7 papers) and Cancer, Stress, Anesthesia, and Immune Response (4 papers). Chen S. Suen collaborates with scholars based in United States, Italy and United Kingdom. Chen S. Suen's co-authors include William W. Chin, Thomas P. Burris, Philippe Delerive, Yifei Wu, Philippe Delerive, Xian‐Cheng Jiang, Robert J. Schmidt, Timothy P. Ryan, Thomas Beyer and Keith A. Otto and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Chen S. Suen

23 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chen S. Suen United States	13	345	265	178	122	120	23	690
Balachandar Nedumaran South Korea	12	406 1.2×	196 0.7×	69 0.4×	176 1.4×	83 0.7×	19	721
Rosemary M. Cesario United States	8	777 2.3×	265 1.0×	82 0.5×	141 1.2×	275 2.3×	8	1.0k
Shunxing Rong United States	12	295 0.9×	207 0.8×	85 0.5×	110 0.9×	35 0.3×	15	659
Jonas Abdel‐Khalik United Kingdom	16	480 1.4×	439 1.7×	204 1.1×	124 1.0×	44 0.4×	23	787
Wendy S. Rosebury United States	11	496 1.4×	265 1.0×	93 0.5×	87 0.7×	23 0.2×	15	837
Sarah Hummasti United States	8	564 1.6×	577 2.2×	169 0.9×	200 1.6×	180 1.5×	8	1.3k
Fjodor H. van der Sluijs Netherlands	8	383 1.1×	462 1.7×	236 1.3×	150 1.2×	33 0.3×	8	834
Laura Tinti Italy	14	376 1.1×	211 0.8×	35 0.2×	204 1.7×	154 1.3×	25	763
C Pacot France	9	707 2.0×	312 1.2×	95 0.5×	133 1.1×	67 0.6×	14	968
Hannah J. Welters United Kingdom	17	417 1.2×	522 2.0×	42 0.2×	253 2.1×	172 1.4×	24	937

Countries citing papers authored by Chen S. Suen

Since Specialization

Citations

This map shows the geographic impact of Chen S. Suen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen S. Suen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen S. Suen more than expected).

Fields of papers citing papers by Chen S. Suen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen S. Suen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen S. Suen. The network helps show where Chen S. Suen may publish in the future.

Co-authorship network of co-authors of Chen S. Suen

This figure shows the co-authorship network connecting the top 25 collaborators of Chen S. Suen. A scholar is included among the top collaborators of Chen S. Suen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen S. Suen. Chen S. Suen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madka, Venkateshwar, Gaurav Kumar, Gopal Pathuri, et al.. (2021). Proton Pump Inhibitor Omeprazole Suppresses Carcinogen-induced Colonic Adenoma Progression to Adenocarcinoma in F344 Rat. Cancer Prevention Research. 14(11). 1009–1020. 6 indexed citations

Jarrard, David F., Wei Huang, KyungMann Kim, et al.. (2020). A phase II randomized placebo‐controlled trial of pomegranate fruit extract in men with localized prostate cancer undergoing active surveillance. The Prostate. 81(1). 41–49. 24 indexed citations

Mohammed, Altaf, Mark Steven Miller, Ronald A. Lubet, et al.. (2019). Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers. Cancer Prevention Research. 13(3). 273–282. 8 indexed citations

Murillo, Genoveva, Xinjian Peng, Miguel Muzzio, et al.. (2019). Abstract 2730: Exceptional activity of ARN-509 (apalutamide) in prostate cancer prevention in rats. Cancer Research. 79(13_Supplement). 2730–2730. 1 indexed citations

Mohammed, Altaf, Naveena B. Janakiram, Venkateshwar Madka, et al.. (2019). Intermittent Dosing Regimens of Aspirin and Naproxen Inhibit Azoxymethane-Induced Colon Adenoma Progression to Adenocarcinoma and Invasive Carcinoma. Cancer Prevention Research. 12(11). 751–762. 12 indexed citations

Mohammed, Altaf, Naveena B. Janakiram, Venkateshwar Madka, et al.. (2018). Abstract 4983: Intermittent dosing regimens of naproxen and aspirin inhibit azoxymethane-induced rat colon adenoma progression to adenocarcinoma and carcinoma invasion. Cancer Research. 78(13_Supplement). 4983–4983. 3 indexed citations

Janakiram, Naveena B., Altaf Mohammed, Jagan M.R. Patlolla, et al.. (2017). Abstract 5260: NGS Transcriptome analysis of colon adenocarcinomas treated with individual and combination of aspirin and omeprazole. Cancer Research. 77(13_Supplement). 5260–5260. 1 indexed citations

Montrose, David C., Xi Kathy Zhou, Rhonda K. Yantiss, et al.. (2016). Celecoxib Alters the Intestinal Microbiota and Metabolome in Association with Reducing Polyp Burden. Cancer Prevention Research. 9(9). 721–731. 35 indexed citations

Provinciali, Nicoletta, Chen S. Suen, Barbara K. Dunn, & Andrea DeCensi. (2016). Raloxifene hydrochloride for breast cancer risk reduction in postmenopausal women. Expert Review of Clinical Pharmacology. 9(10). 1263–1272. 21 indexed citations

10.

Antonides, Jennifer D., Beverly R. Wuertz, Wendy A. Miller, et al.. (2016). Safety and Preclinical Efficacy of Aerosol Pioglitazone on Lung Adenoma Prevention in A/J Mice. Cancer Prevention Research. 10(2). 124–132. 17 indexed citations

11.

Janakiram, Naveena B., Altaf Mohammed, Gopal Pathuri, et al.. (2016). Abstract 2604: Chemoprevention of colorectal cancer by LFA-9, a novel dual mPGES-1/5-LOX inhibitor: safer approaches to chemoprevention. Cancer Research. 76(14_Supplement). 2604–2604. 1 indexed citations

12.

Briere, Daniel A., Xiaoping Ruan, Christine C. Cheng, et al.. (2015). Novel Small Molecule Agonist of TGR5 Possesses Anti-Diabetic Effects but Causes Gallbladder Filling in Mice. PLoS ONE. 10(8). e0136873–e0136873. 66 indexed citations

13.

Shoemaker, Robert H., et al.. (2015). The National Cancer Institute’s PREVENT Cancer Preclinical Drug Development Program: overview, current projects, animal models, agent development strategies, and molecular targets. Seminars in Oncology. 43(1). 189–197. 4 indexed citations

14.

Mohammed, Altaf, Jagan M.R. Patlolla, Yuting Zhang, et al.. (2015). Abstract 2820: Omeprazole alone, or in combination with Aspirin inhibits azoxymethane-induced colon adenoma progression to adenocarcinoma and carcinoma invasion in F344 rat model. Cancer Research. 75(15_Supplement). 2820–2820. 2 indexed citations

15.

Carson, Matthew W., J.G. Luz, Chen S. Suen, et al.. (2014). Glucocorticoid Receptor Modulators Informed by Crystallography Lead to a New Rationale for Receptor Selectivity, Function, and Implications for Structure-Based Design. Journal of Medicinal Chemistry. 57(3). 849–860. 25 indexed citations

16.

Suen, Chen S. & Paul Burn. (2011). The potential of incretin-based therapies in type 1 diabetes. Drug Discovery Today. 17(1-2). 89–95. 18 indexed citations

17.

Cao, Guoqing, Liang Yu, Carol L. Broderick, et al.. (2003). Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis. Journal of Biological Chemistry. 278(2). 1131–1136. 239 indexed citations

18.

Delerive, Philippe, William W. Chin, & Chen S. Suen. (2002). Identification of Reverbα as a Novel RORα Target Gene. Journal of Biological Chemistry. 277(38). 35013–35018. 50 indexed citations

19.

Delerive, Philippe, Yifei Wu, Thomas P. Burris, William W. Chin, & Chen S. Suen. (2002). PGC-1 Functions as a Transcriptional Coactivator for the Retinoid X Receptors. Journal of Biological Chemistry. 277(6). 3913–3917. 83 indexed citations

20.

Ray, David, Chen S. Suen, Andy Brass, J. Soden, & Anne White. (1999). Structure/Function of the Human Glucocorticoid Receptor: Tyrosine 735 Is Important for Transactivation. Molecular Endocrinology. 13(11). 1855–1863. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact